Cullgen (Shanghai),Inc
2 clinical trials · Sponsor
◉ Watch Cullgen (Shanghai),Inc
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies (NCT07347171) | Cullgen (Shanghai),Inc | 2025-04-17 |
| A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities (NCT07394374) | Cullgen (Shanghai),Inc | 2023-06-20 |
Track Cullgen (Shanghai),Inc automatically
Every clearance here is in the API, with alerts when new ones post.